Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2023-11-07 Regulatory Filings
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Clinical Trial launched at Gold Coast Hospital 2 pages 179.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 8 November 2023 about the launch of a clinical trial at Gold Coast Hospital by HeraMED Limited. It describes the trial's objectives, milestones, and collaboration details. There are no financial statements, regulatory certifications, voting results, or management changes. The content is a corporate announcement about a clinical trial initiation, not a financial report, earnings release, or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is a general corporate announcement about a clinical trial launch, which is best classified under Regulatory Filings (RNS) as a miscellaneous announcement that does not fit other specific categories.
2023-11-07 English
Quarterly Activities & Cashflow Report 11 pages 653.6KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activities & Cashflow Report' and dated 31 October 2023, covering Q3 FY23. It provides detailed operational updates, financial figures including cash balance, receipts, and expense components for the quarter. The content includes progress on commercialization strategy, partnerships, pipeline updates, and financial overview with specific quarterly data. The length is substantial (15,000 characters) and contains actual financial and operational data, not just an announcement or summary. This matches the characteristics of an Interim / Quarterly Report (IR), which includes comprehensive financial data and analysis for a period shorter than a full fiscal year. Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q3 2023
2023-10-30 English
Notification regarding unquoted securities - HMD 7 pages 31.9KB
Capital/Financing Update Classification · 100% confidence The document is a notification regarding the issue of unquoted equity securities, specifically director options issued as part of a remuneration package. It details the number of securities issued, the approval by shareholders, and the terms of the securities. The document is an announcement of a capital issuance event rather than a full financial report or other types of filings. It fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising or capital structure changes. The document length and content confirm it is not a brief announcement or a report publication notice, but a substantive notification of a capital event.
2023-10-08 English
Change of Director's Interest Notice - Ron W 3 pages 292.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of shares and options acquired, dates of changes, and nature of the interests. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transactions, which fits the definition of Director's Dealing filings. The document length is under 5,000 characters and is a direct report of a director's interest change, not an announcement of a report or certification. Therefore, the correct classification is Director's Dealing (DIRS).
2023-10-08 English
Results of Meeting 2 pages 304.8KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 19 September 2023 reporting the results of a General Meeting. It includes detailed proxy vote counts and outcomes for resolutions passed at the meeting. The text references the Corporations Act 2001 and provides voting results for shareholder resolutions. There is no financial data, management discussion, or report attached; it is purely an announcement of voting results from a shareholder meeting. According to the filing definitions, this fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused solely on voting results, confirming it is not a full report or presentation.
2023-09-18 English
Appendix 4D and Half Year Report 24 pages 844.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ASX APPENDIX 4D HALF-YEAR FINANCIAL REPORT TO 30 JUNE 2023' and contains detailed financial information for the half-year ended 30 June 2023, including consolidated statements of profit or loss, financial position, cash flows, and notes. It includes a directors' report, auditor's review report, and other comprehensive financial data. The presence of detailed financial statements and analysis for a half-year period clearly identifies this as an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification but contains substantive financial data and management commentary. Therefore, the correct classification is 'IR' (Interim / Quarterly Report). H1 2023
2023-08-17 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.